Drugmakers’ marketing expenses rise

Government-imposed price cuts of the past year had drug companies scramble to tighten their purse strings, but they perhaps considered marketing expenses as too important to rein in ― their promotional outlays have been resurged amid the economic slump.

To boost their sluggish sales, leading drug firms began increasing the ratio of its marketing expenses to sales up to 10 percent over the pr...